| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.085 | 0.08 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |